Attached files

file filename
EX-23.2 - EX-23.2 - YIELD10 BIOSCIENCE, INC.a17-28240_8ex23d2.htm
EX-23.1 - EX-23.1 - YIELD10 BIOSCIENCE, INC.a17-28240_8ex23d1.htm
EX-5.1 - EX-5.1 - YIELD10 BIOSCIENCE, INC.a17-28240_8ex5d1.htm

As filed with the Securities and Exchange Commission on December 18, 2017

Registration No. 333-          

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-1

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

YIELD10 BIOSCIENCE, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

2870

 

04-3158289

(State or Other Jurisdiction of
Incorporation or Organization)

 

(Primary Standard Industrial
Classification Code Number)

 

(I.R.S. Employer
Identification Number)

 

19 Presidential Way

Woburn, Massachusetts 01801

(617) 583-1700

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

 

Dr. Oliver P. Peoples

President & Chief Executive Officer

Yield10 Bioscience, Inc.

19 Presidential Way

Woburn, Massachusetts 01801

(617) 583-1700

(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)

 

Copies to:

 

Megan N. Gates, Esq.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, Massachusetts 02111
(617) 542-6000

 

Michael Nertney, Esq.
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
(212) 370-1300

 

Approximate date of commencement of proposed sale to the public:

As soon as practicable after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), check the following box. o

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. x      File No. 333-221283

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

Accelerated filer

o

 

Non-accelerated filer   o  (Do not check if a smaller reporting company)

Smaller reporting company

x

 

 

Emerging growth company

o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o

 

CALCULATION OF REGISTRATION FEE

 

Title of Each Class of Securities to be Registered

 

Proposed Maximum
Aggregate
Offering Price(1)(2)

 

Amount of
Registration Fee

 

Class A Units consisting of:

 

$

— 

 

 

(i) Shares of common stock, par value $0.01 per share

 

 

 

 

 

(ii) Series A Warrants to purchase common stock

 

 

 

 

 

(iii) Series B Warrants to purchase common stock

 

 

 

 

 

Class B Units consisting of:

 

$

— 

 

 

(i) Shares of Series A Preferred Stock, par value $0.01

 

 

 

 

 

(ii) Shares of common stock issuable on conversion of Series A Preferred Stock (3)

 

 

 

 

 

(iii) Series A Warrants to purchase common stock

 

 

 

 

 

(iv) Series B Warrants to purchase common stock

 

 

 

 

 

Common Stock issuable upon exercise of Warrants

 

$

— 

 

 

Total

 

$

6,037,500.00 

 

$

751.67

 

 

(1)          Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

(2)          Includes the price of additional shares of common stock and warrants to purchase shares of common stock that the underwriters have the option to purchase to cover over-allotments, if any.

(3)          No separate fee is required pursuant to Rule 457(i) under the Securities Act.

 

This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended.

 

 

 



 

EXPLANATORY NOTE AND INCORPORATION OF
CERTAIN INFORMATION BY REFERENCE

 

This Registration Statement is being filed with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This Registration Statement incorporates by reference the contents of, including all amendments and exhibits thereto and all information incorporated by reference therein, the Registration Statement on Form S-1 (Registration No. 333-221283), which was declared effective by the Commission on December 18, 2017, and is being filed solely for the purpose of registering an increase in the maximum aggregate offering price of $6,037,500. The required opinions and consents are listed on the Exhibit Index attached hereto.

 

2


 



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Woburn, Massachusetts, on December 18, 2017.

 

 

YIELD 10 BIOSCIENCE, INC.

 

 

 

 

By:

/s/ Oliver P. Peoples

 

 

Oliver P. Peoples

President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Oliver P. Peoples

 

Director, President and Chief Executive Officer

 

December 18, 2017

Oliver P. Peoples

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Charles B. Haaser

 

Chief Accounting Officer

 

December 18, 2017

Charles B. Haaser

 

(Principal Financial Officer and Principal Accounting Officer)

 

 

 

 

 

 

 

By:

*

 

Director

 

December 18, 2017

Joseph Shaulson

 

 

 

 

 

 

 

 

 

By:

*

 

Director

 

December 18, 2017

Peter N. Kellogg

 

 

 

 

 

 

 

 

 

By:

*

 

Director

 

December 18, 2017

Richard Hamilton

 

 

 

 

 

 

 

 

 

By:

*

 

Director

 

December 18, 2017

Anthony J. Sinskey

 

 

 

 

 

 

 

 

 

By:

*

 

Director

 

December 18, 2017

Robert L. Van Nostrand

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* By:

/s/ Oliver P. Peoples

 

 

 

 

 

Oliver P. Peoples

 

 

 

 

 

Attorney-in-Fact

 

 

 

 

 

4